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1. Introduction 
Human African trypanosomiasis, also known as sleeping sickness, is a vector-borne 
parasitic disease. The parasites concerned are protozoa belonging to the Trypanosoma genus. 
They are transmitted to humans by tsetse fly (Glossina genus) which have acquired their 
infection from human beings or from animals harbouring the human pathogenic parasites. 
Rural populations living in regions where transmission occurs and which depend on 
agriculture, fishing, animal husbandry or hunting are the most exposed to the disease. 
Sleeping sickness threatens millions of people in 36 countries in sub-Saharan Africa. Many 
of the affected populations live in remote areas with limited access to adequate health 
services. Treatment depends on drugs that can cross the blood-brain barrier to reach the 
parasite. Such drugs are toxic and complicated to administer. Suramin, discovered in 1921, 
is one of the drugs used for the treatment. However, it provokes certain undesirable effects, 
in the urinary tract and allergic reactions. Other drugs in use are equally toxic and difficult 
to administer. Thus the need to develop new drugs is imperative. Natural products and 
medicinal plants (Antia et al, 2009; Sara et al, 2004; Bizimana et al., 2006; Okpekon et al., 
2004) have continued to contribute to the search for new and potent anti-trypanosomal 
drugs with minimal side effects. Their continued relevance in drug discovery and 
development is due to their bioactivity, biodiversity and reported safety in their use. An 
analysis of new and approved drugs for the treatment of human diseases indicated that 
natural products have continued to play a highly significant role in the drug discovery and 
development process. Thus biologically active natural products from plants, their 
derivatives or analogues contributed up to 57% of top selling prescription drugs in the 
United States in 1997 (Newman et al., 1997). This dominant role is due to the leads for the 
development of drugs that natural products give. Thus expanding, not decreasing, the 
exploration of nature as a source of novel active agents that may serve as leads and scaffolds 
for elaboration into desperately needed efficacious drugs for a multitude of disease 
indications is advocated (Newman & Cragg, 2007).  Ethnobotanical surveys have revealed 
the use of Alcornea cordifolia, Euphorbia poisonii, Monodora myristica, Prosopis africana, Spondias 
mombim, Nauclea pobeguinii, Terminalia avicennioides, Cochlospermum planchonii, Nauclea 
latifolia and Withania somnifera in the traditional medicine in parts of Nigeria (Igoli et. al., 
2005). These plants are used as spices and medicinally for the treatment of diarrhoea, 
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dysentery, diabetes, bacterial infections, fevers, pain and snake bites amongst other ailments 
by the Igede people of Benue State in Nigeria. Maytenus laevis is used in traditional medicine 
in Colombia (Nagakawa et.al., 2004; Gonzalez et al., 1982) against pain and arthritis. Before 
the introduction of synthetically prepared medicines, herbal remedies were commonly 
prescribed and were often effective. Thus herbs and spices played very important, 
sometimes magical, roles in medicine. Hence these plants were collected and their extracts/ 
compounds isolated were evaluated for anti-trypanosomal and cytotoxic activities. A high 
throughput (HTS) method was used to screen the extracts and compounds. This has become 
very useful in modern drug discovery from natural products. It is a form of standardised 
and replicate screening method which employs 96 well plates which can be used to screen 
80 extracts, compounds or fractions at the same time. It can also be adapted to obtain data to 
plot dose response curves and determine IC50 and MIC values. Using a multilabel counter, 
suitable indicators, wells with extracts, cells, organisms and controls can be read quickly by 
examining fluorescence, luminescence and optical density or by radiometry giving exact 
and replicable values free from errors of visual determinations or measurements. The 
volumes used in these wells are between 200-250µL and for half well plates 20-40µL such 
that solutions of extracts or compounds as low as 1mg dissolved in 100µL gives a stock 
solution of 10mg/ml which can be diluted for all range of concentrations typically from 20-
30µg/ml to ng or µM to nM values using serial dilution methods. This greatly enhances 
speed and efficacy of screening for hit molecules (Gray et al., 2011). Efforts were made to 
identify the active compounds contained in the extracts as much as possible. This is because 
it is the practice today to screen more and more pure compounds rather than crude extracts 
or fractions. Screening of crude extracts or mixtures/fractions does not allow understanding 
of the mode of activity of the test compounds against the target cells or tissues. Isolation of 
the active compounds is required before active concentrations can be determined. We 
hereby report on these plant extracts, the compounds obtained from them, their in vitro 
activity against the bloodstream form of Trypanosoma brucei brucei (T.b.brucei) and the 
cytotoxic activity of the active compounds/extracts against PNT2A cells. 
2. Materials and methods 
Standard methods of extraction and isolation or purification of compounds/extracts from 
plant materials were used while a standardised 96 well based assay was used to screen the 
extracts for anti-trypanosomal activity and cytotoxicity. The crude extracts as well as pure 
compounds obtained were screened in vitro for trypanosomal activity against Trypanosoma 
brucei brucei (S427) blood stream forms. Active compounds from the preliminary screens 
were further tested to confirm activity and determine their minimum inhibitory 
concentration (MIC) values.  Cytotoxicity of the active compounds and extracts was then 
tested against PNT2A cells (“normal” prostatic cells). 
2.1 General bioassay 
The anti-trypanosomal and cytotoxicity assays were performed using the REDOX indicator 
Alamar blue™. The active component of which is resazurin (blue in colour) which in the 
presence of live parasites or cells is reduced to the bright pink fluorescent resorufin. The 
fluorescence values for the test plates are measured using a microplate reader in 
fluorescence mode with excitation and emission wavelengths of 560 and 590nm respectively.  
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Wells containing active compounds are easily identified as they remain blue in colour and 
have background levels of fluorescence. The test samples are initially screened at a single 
concentration and then MIC or IC 50 values are determined for the active compounds at n=2 
or n=3. Positive and negative controls and a sterility checks are included in all assays. The 
incubation and treatment times, incubation conditions and seeding densities are optimised 
for each test species and cell line. 
2.1.1 Anti-trypanosomal activity 
Samples were tested against the bloodstream form of Trypanosoma brucei brucei (T.b.brucei) 
S427. The activity of the plant extracts and isolated compounds was determined using 
the well-established Alamar blue™ 96 well microplate assay. Samples were initially 
screened at a single concentration usually 20µg/ml for extracts or 20µM for pure 
compounds. The concentration of dimethylsulphoxide (DMSO) should not exceed 0.5% in 
the initial screen. 
Samples for testing were prepared as 10mg/ml or 10mM stock solutions in 100% DMSO. 
These were diluted with HMI-9 medium to a concentration of 1mg/ml /1mM. 4µl of the test 
sample was added to the assay well then 96µl HMI-9 medium to give a final assay 
concentration after a 1:1 dilution of 20µg/ml / 20µM.  
 1 2 3 4 5 6 7 8 9 10 11 12 
A Sterility control 1 2 3 4 5 6 7 8 9 10 1.0µM 
suramin 
B control 11 12 13 14 15 16 17 18 19 20 0.5µM 
suramin 
C control 21 22 23 24 25 26 27 28 29 30 0.25µM 
suramin  
D control 31 32 33 34 35 36 37 38 39 40 0.125µM 
suramin 
E DMSO control 41 42 43 44 45 46 47 48 49 50 0.062µM 
suramin  
F DMSO control 51 52 53 54 55 56 57 58 59 60 0.031µM 
suramin 
G DMSO control 61 62 63 64 65 66 67 68 69 70 0.015µM 
suramin  
H DMSO control 71 72 73 74 75 76 77 78 79 80 0.008µM 
suramin 
Table 1. Anti-trypanosomiasis assay plate layout. 
The screening plate was arranged as illustrated in Table 1. Controls including a sterility 
control and DMSO controls in column 1; test samples in columns 2 to 11 and a concentration 
range of suramin as a positive control in column12. Trypanosomes were counted using a 
haemocytometer and diluted to a concentration of 3x104 trypanosomes /ml, 100µl of this 
suspension was added to each well of the assay plate with the exception of well A1 the 
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sterility check. The assay plate was incubated at 37ºC, 5% CO2 with a humidified 
atmosphere for 48 hours. After which 20µl of Alamar blue was added and the incubation 
continued for a further 24 hours. Fluorescence was then determined using the Wallac Victor 
microplate reader (Excitation 530nm Emission 590nm). The results were calculated as % of 
the DMSO control values. Minimum inhibitory concentration values (MICs) were 
determined for samples with less than 10% of control values. MIC determinations were 
carried out in duplicate. 200µg/ml test solutions were prepared in column 2 by pipetting 4µl 
of (10mg/ml) test stock solution and 196µl HMI-9 medium into each well. 100µl HMI-9 
medium was pipetted into columns 1 and 3-12 and 1:1 serial dilutions were carried out from 
columns 2 to 11. 80µl of HMI-9 medium was added to column 12 and 20µl of x10 
concentrations of suramin to give a final concentration range of 0.008 to 1.0µM. An 
inoculum of 100µl of trypanosomes at a concentration of 3x104/ml was added to each well 
except A1, and the procedure continued as previously described. 
 
 1 2 3 4 5 6 7 8 9 10 11 12 
A control 100 50 25 12.5 6.25 3.1 1.55 0.78 0.34 0.17 1.0µM 
suramin 
B control 100 50 25 12.5 6.25 3.1 1.55 0.78 0.34 0.17 0.5µM 
suramin 
C control 100 50 25 12.5 6.25 3.1 1.55 0.78 0.34 0.17 0.25µM 
suramin  
D control 100 50 25 12.5 6.25 3.1 1.55 0.78 0.34 0.17 0.125µM 
suramin 
E control 100 50 25 12.5 6.25 3.1 1.55 0.78 0.34 0.17 0.062µM 
suramin  
F control 100 50 25 12.5 6.25 3.1 1.55 0.78 0.34 0.17 0.031µM 
suramin 
G control     1% 
DMSO
0.5% 
DMSO
0.25%
DMSO
0.12%
DMSO
0.06%
DMSO
0.03%
DMSO
0.01%
DMSO
0.00%
DMSO
0.00%
DMSO
0.00% 
DMSO 
0.015µM 
suramin  
H control     1% 
DMSO
0.5% 
DMSO
0.25%
DMSO
0.12%
DMSO
0.06%
DMSO
0.03%
DMSO
0.01%
DMSO
0.00%
DMSO
0.00%
DMSO
0.00% 
DMSO 
0.008µM 
suramin 
Table 2. Final assay concentrations µg/ml 
MIC values were determined as the concentration calculated to have < 5% of control values. 
2.1.2 Cytotoxicity determinations 
Cytotoxicity determinations were carried out using a modification the Alamar blue™ redox-
based microplate assay (O’Brien et al., 2000). The cytotoxic activity of the fractions and 
compounds was initially determined against PNT2A cells a “human” normal prostatic 
epithelial cell line. Initial screening was carried out at a concentration of 100µg/ml. 
Concentration response studies (300 to 0.3µg/ml) were then carried out in duplicate for 
samples with less than 60% of control values in the initial screen.  
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Cells were seeded into 96 well microplates at a density of 0.5 x 104 cells/well in 100µl 
Dulbecco’s modified Eagle’s medium (DMEM; Invitrogen) and incubated at 37ºC, 5% CO2 
with a humidified atmosphere for 24 hours. After which DMEM solutions of test 
compounds at the desired concentrations and DMSO as a negative control and 0.1% Triton 
X as a positive control were added to give a total well volume of 200µl. The microplates 
were incubated for 24 hours before the addition of 10µl of alamar blue. After a further 20 
hours incubation fluorescence was determined using a Wallac Victor microplate reader in 
fluorescence mode (Excitation 530nm; Emission 590nm). The results were calculated as % of 
the DMSO control values. IC50 values were calculated for the concentration response data 
using Graphpad prism software.  
2.2 Isolation and structure elucidation of compounds 
Melting points (uncorr.) were determined on a Buchi B-540 melting point apparatus. The 
1H NMR and 13C NMR spectra were run on a Bruker AV 300 (400MHz) and DRX 500 
spectrometers using CDCl3 or DMSO-d6 as solvents and TMS as internal standard. 
HRESI-MS were run using Thermo LTQ Orbitrap or Thermo Exactive orbitrap mass 
spectrometer. A capillary voltage of 46.00V for the positive mode and -48.00V for the 
negative mode was used for HRESI-MS. Column chromatography were performed using 
silica gel MN-60 (Macherey-Nagel GmbH & Co. KG) and Gel filtration chromatography 
using Sephadex LH-20 (GE Health Lifescience UK) were performed in glass columns. 
Spots on TLC were visualised using Anisaldehyde-H2SO4 reagent or Dragendorff’s 
reagent for the alkaloids. Developed TLC plates were also observed under UV lamp using 
short (λ= 254 nm) and long (λ= 366 nm) wavelengths. The structures of the pure 
compounds were determined using spectroscopic methods (1D/2D NMR and mass 
spectrometry). Column chromatography (CC) were carried out on wet packed silica gel in 
glass columns eluting gradient wise with hexane, hexane-ethyl acetate, ethyl acetate and 
ethyl acetate-methanol mixtures or with Sephadex LH-20 pre-soaked and wet packed in 
methanol. After the introduction of the extracts or fractions in methanol, the Sephadex 
columns were also eluted with methanol. TLC analysis was performed on pre-coated 
silica gel aluminum plates cut to desired size. NMR experiments were run in CDCl3 or 
DMSO-d6 with TMS as internal standard on Bruker AV 300 (400MHz) or DRX-500 
spectrophotometer.  
2.2.1 Plant materials 
All plant materials were collected from Oju LGA Benue State, Nigeria between July and 
September 2008. The plants were authenticated by the Department of Forestry and Wildlife 
of the University where voucher specimens were deposited in the University of Agriculture 
Forest Herbarium. Alcornea cordifolia (bark), Euphorbia poisonii (stem), Monodora myristica 
(seeds), Prosopis Africana (bark), Spondias mombim (root), Nauclea pobeguinii (bark), Nauclea 
latifolia (bark), Cochlospermum planchonii(root) and Withania somnifera (whole plant), 
Terminalia avicennioides (bark). Maytenus laevis (root) was from samples already housed at the 
Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS). They were all sun dried 
in open air and ground using a mill. 
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2.2.2 Extraction and identification of the components 
The plant materials (500g – 1.0kg) were air dried and extracted using hexane, ethyl acetate 
and methanol in a Soxhlet apparatus. The crude extracts were allowed to stand and 
sometimes cooled to allow for the precipitation of compounds. Where all precipitates have 
been produced or no (further) precipitation, the crude extracts or precipitates (where not a 
pure compound) were subjected to column chromatography (CC) eluting gradient- wise 
using hexane-ethyl acetate and subsequently ethyl acetate-methanol solvent mixtures. Using 
TLC as a guide, similar fractions were combined and allowed to evaporate under the fume 
hood to allow for the crystallisation of pure compounds. Where no pure compounds were 
separated and the fractions were active, such fractions were further purified via preparative 
thin layer chromatography or Gel filtration (GF) using Sephadex LH-20 to obtain the pure 
compounds. Methanol extracts which were usually viscous and complex were subjected to 
an initial vacuum liquid chromatography (VLC) to fractionate the extracts. Similar fractions 
(TLC) were also combined and further purified via column chromatography or Gel 
filtration. Flash chromatography using an iES Reveleris Automated Flash Chromatography 
system was used for the isolation of certain compounds. The column was dry packed after 
taking up the extracts with silica gel and then loaded onto the pre-packed flash column. The 
compounds were eluted starting with hexane with incremental additions of ethyl acetate, 
then with ethyl acetate with additions of methanol and finally with methanol. Using two 
variable length UV detectors and one ELSD detector, similar eluates were combined and 
confirmed by TLC and 1H NMR. Pure compounds were then allowed to settle out from the 
combined fractions. All columns were exhaustively eluted and washed with methanol. 
Washings were allowed to stand to allow for the precipitation of compounds. The 
identification of pure compounds was carried out using one dimensional 1H and 13C NMR 
spectroscopy (including J-mod, DEPT-q and DEPT 135 or 90). Spectral data of known 
compounds were compared with published spectral data and were thereby identified. 
Further 2D experiments (including correlation spectroscopy (COSY), heteronuclear multiple 
quantum coherence (HMQC), heteronuclear multiple bond correlation (HMBC) and nuclear 
overhauser enhancement spectroscopy (NOESY)) were carried out for more complex 
molecules for accurate assignments of proton and carbon chemical shifts. Assigned 
structures were confirmed using ESI-MS and HRESI-MS to confirm their mass and 
molecular formula. The various extracts produced are listed in table 3 below. Extract code 
descriptions or extensions are: precipitate (P), latex (L), Sephadex (S), methanol wash (w), 
VLC fraction (V), flash chromatography fraction (F), root (R), bark (B).  
3. Results 
3.1 Anti-trypanosomal screening 
The photographs below show the results from the concentration response studies to determine 
the MIC of the triterpenoids (compounds 11 and 12) from M.laevis. Well A1 is the sterility 
check, wells B1 to H1 negative controls and wells G2 to G11 and H2 to H11 are the DMSO 1:1 
dilution controls. Column 12 contains a concentration range of 1 to 0.008µM of the positive 
control suramin. In plate 1 compounds 11 (rows C and D) and 12 (rows E and F) are tested n=2 
over a concentration range of 100 to 0.17µM. In plate 2 compounds 11 (rows A, B and C) and 
12 (rows D,E and F) are tested  n=3 over a concentration range of 10 to 0.02µM. 
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S/No Plant Part Extract codes 
Hexane 
(H) 
Ethyl 
acetate 
(E) 
Combined 
hexane + ethyl 
acetate (HE) 
Methanol (M) 
1 Alcornea cordifolia Bark (B) ACBH ACBE ACBHE ACBM 
2 Cochlospermum 
planchonii 
Root (R) CPH CPE CPHE CPM 
3 Euphorbia poisonii Stem EPH EPE EPHE EPM 
4 Maytenus laevis Root (R) MLH MLE MLHE MLM 
5 Monodora 
myristica 
Seed MMH MME MMHE MMM 
6 Nauclea latifolia Bark (B) NLH NLE NLHE NLM 
7 Nauclea pobeguinii Bark (B) NPH NPE NPHE NPM 
8 Prosopis Africana Bark (B) PAH PAE PAHE PAM 
9 Spondias mombim Root (R) SMH SME SMHE SMM 
10 Terminalia 
avicennioides 
Bark (B) TAH TAE TAHE TAM 
11 Withania 
somnifera 
Whole 
plant 
WSH WSE WSHE WSM 
Table 3. Extracts produced from the plant materials 
 
 
Plate 1. Photo showing MIC of compounds 11 and 12. 
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Plate 2. Photo showing MIC of compounds 11 and 12. 
The anti-trypanosomal activity and cytotoxicity against PNT2A cell lines observed for the 
extracts, fractions and compounds are given in the table below. 
 Extract/ 
Fraction 
Compound/ 
Remarks 
Anti-trypanosomal activity Cytotoxicity 
% of Control    
(20 µg/ml) 
MIC 
(µg/ml) 
% of Control 
(100 µg/ml) 
IC50 
(µg/ml) 
1 ACBE-1 8 13.3  42.8  
2 ACBM-12 3 3.8 <0.2 29.9 1.5 
3 ACBM-14 7 18.0  28.5 24.2 
4 PAM-5 Column fraction 12.5    
5 PAM-6 Column fraction 19.4    
6 WSE-1a Column fraction 12.5 12.5   
7 WSE-1b Column fraction 12.5 12.5   
8 WSE-1c Column fraction 3.12 3.12   
9 MMH-1 Crude extract 8.0 12.5   
10 MME-5 Column fraction -1.2 3.125   
11 MME-10 Column fraction -1.4 3.125   
12 MMS-28  9 & 10 -1.4 6.25   
13 MME-29 Column fraction -1.3 3.125   
14 MME-41 10 6.5 12.5   
15 MME-42 9 6.5 25   
16 EPLE-1 Column fraction 0.8  64.5  
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 Extract/ 
Fraction 
Compound/ 
Remarks 
Anti-trypanosomal activity Cytotoxicity 
% of Control    
(20 µg/ml) 
MIC 
(µg/ml) 
% of Control 
(100 µg/ml) 
IC50 
(µg/ml) 
17 EPLE-5 Column fraction -0.1 6.25 29.6  
18 EPP-1 6 1.3 1.56   
19 EPH-1 Crude extract -0.2    
20 EPHE-w  5 -0.7    
21 TASW-2 14 33.6    
22 TAHE-1 Crude extract 8.7    
23 TAHE-4 Column fraction 5.2 2.5   
24 NPE-5 Column fraction 0.8    
25 NPE-7 Column fraction 4.9 6.25 9.7 >100 
26 NPE-13 Column fraction 4.4 12.5 44.2 >100 
27 NPE-48 1 6.4 12.5 42.8 >100 
28 NPM-10 Column fraction 28.1  43.9 7.7 
29 SMHE-44 2 -0.2 25 87.5  
30 SMM-9 4 31.6  50  
31 MLHEF-14 11 3.8 0.625   
32 MLHEF-18 12 6.1 0.625   
33 WSM-w 13 78.7    
34 WSH-1 Crude extract 50.0 50.0   
35 WSH-2 Column fraction 25.0 25.0   
36 WSH-3 Column fraction 50.0 50.0  
37 MMH-3 Column fraction 6.25 6.25  
38 MMH-0 Crude extract 25.0 25.0  
39 MMH-4 Column fraction 50.0 50.0  
40 ACRHE-20 Column fraction 20 85.0  
41 NPE-57 15 100 87.8  
42 NPE-81 16 100  
43 EPH-1.4 Column fraction 100 81.2  
44 EPH-1.1 Column fraction -0.2 12.5 76.4  
45 EPH-1.6 Column fraction 107.8 79  
46 ACBME-2 Column fraction 91.0 83.2  
47 ACBHE-6 Column fraction 80.3 89.3  
48 SMHE-7 Column fraction 92.3 92.7  
49 SMHE-13 Column fraction 96.3 87.5  
50 ACRM-1 Crude extract 95.8 87.5  
51 MMM-1 Crude extract 108.2  
52 MMEV-12 VLC fraction -0.4  
53 MMEV-17 VLC fraction 0.9  
Table 4. Activity of crude extracts, fractions and compounds 
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3.2 Isolated compounds 
The following compounds were isolated from the plants: 
Compound Reference Plant 
1 Hotellier et al. (1980) Nauclea pobeguinii, Nauclea latifolia 
2 Nonaka et al. (1982) Spondia mombin 
3 Lee et al. (1992) Alcornea cordifolia 
4 Nagle et al. (2006) Cocholospermum planchonii, Spondias mombin 
5 Gewali et al. (1990) Euphorbia poisonii
6 Dubery et al. (1999) Euphorbia poisonii 
7 Bankova (1990); Saha et al. (1991) Alcornea cordifolia 
8 Koetter et al. (1989) Alcornea cordifolia 
9 Nkunya et al. (2004) Monodora myristica 
10 Ishii et al (1975) Monodora myristica 
11 Gonzalez et al. (1982) Maytenus laevis 
12 Jeller et al. (2004) Maytenus laevis 
13 Nandy et al. (1989) Withania somnifera 
14 Kim et al. (2001) Terminalia avecinnoides 
15 Cerri et al.(1988) Nauclea pobeguinii, Nauclea latifolia 
16 Cerri et al. (1988) Nauclea pobeguinii, Nauclea latifolia 
Table 5. Isolated compounds and plant sources 
Some of the active compounds were identified (Mass spec and NMR: 1D, 2D including 
COSY, HSQC, HMBC, NOESY) their spectral data were compared with literature reports. 
The structures of the compounds are given in the figure below. 
3.3 NMR data for some isolated compounds 
 
Position 
Compound 9 Compound 10 
1H 13C 1H 13C 
1 8.57 br.s (NH) - 8.36 br.s (NH) - 
2 7.34 dd (J=2.8, 3.2 Hz) 126.0 (CH) 7.27 m 125.4 (CH) 
3 6.74 ddd (J= 0.8, 2.0, 3.2 Hz) 104.5 (CH) 6.62 m 103.5 (CH) 
4 8.20 d (J= 1.2 Hz) 126.2 (CH) 7.85 d (J = 0.8 Hz) 122.7 (CH) 
5 - 129.8 (C) - 126.5 (C) 
6 7.80 dd (J= 1.2, 8.4 Hz) 122.4 (CH) 7.48 dd (J = 8.4, 1.6 Hz) 121.8 (CH) 
7 7.50 d (J= 8.4 Hz) 111.7 (CH) 7.43 d (J = 8.4 Hz) 111.6 (CH) 
8 - 138.8 (C) - 137.9 (C) 
9 - 127.8 (C) - 128.2 (C) 
1` 10.06 s 192.5 (CHO) 2.41 s 27.4 (CH3) 
2` - - - 198.6 (CO) 
3` - - 6.73 d (J = 16.4 Hz) 124.7 (CH) 
4` - - 7.69 d (J = 16 Hz) 145.6 (CH) 
Table 6. The NMR spectra assignments for compounds 9 and 10.  
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Fig. 1. Structures of isolated compounds 
HO
O
OH
COOCH3
R2
11; R1, R2 = H
12; R1 = R2 = O
R1
HO
HO
COOH
13
HO
CH2OH
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4. Discussion 
The beta carboline alkaloids were isolated from the two Nauclea spp. The cathechins and 
their gallates were obtained from A. cordifolia, S. mombim and C. planchonii. Catechins 
including catechin, epicatechin, gallocatechin and five others have been reported to be active 
against nonproliferative bloodstream trypomastigote and intracellular replicative 
amastigote parasite forms of Trypanosoma cruzi (Paveto et al., 2004). The stem of E. poisonii 
afforded the steroidal triterpene and scoporone. The caffeic acid esters were isolated from 
A.cordifolia and there could be a mixture of more esters. The quinonemethide friedelene 
triterpenes were obtained from hexane and ethyl acetate extracts of M. laevis. They showed 
very good activity with MICs of 0.625µg/ml. Other pure compounds obtained are as listed 
on table 2. Some of the pure compounds were however not active when tested. Compound 
13 is one of such as well as compound 14 which did not show very good activity. The results 
of these screening supports a further investigation of the active compounds identified. These 
could be confirmed as hit molecules especially when the compound’s cytotoxicity is low 
showing selectivity which is vital for drug molecules. Compounds that are inimical to the 
growth and survival of microorganisms but do not affect the cells adversely are potential 
candidates for drug development. Some of the extracts and fractions show significant 
activity but the active compounds have not been identified in this study. Such extracts could 
be subject of further investigation to isolate or identify the active components. These results 
also lend credence to some of the ethnobotanical or traditional use of the plants as they are 
mainly used against fevers caused by malarial parasites. Interestingly, the same or similar 
compounds were isolated from the different plant samples. Some belong to the same 
families but others do not. This thus confirms their activity not being due to the crude 
extracts or fractions but the fact that these extracts or fractions contain the same or similar 
compounds. These results may easily pave way for a structure activity study as variations in 
structure and side chains or substituents on similar moieties vis-à-vis activity can easily be 
observed. For instance it can be observed that glycosidation knocks off activity from the test 
compounds.  
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